TRAVERE THERAPEUTICS, INC. Cash
TRAVERE THERAPEUTICS, INC. (TVTX) had Cash of $18.20 million as of 2014-12-31, per its 10-K filed 2015-03-11.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:Cash · last filed 2015-07-09
- 2014-12-31: Cash $18.20M.
- 2014-06-30: Cash $39.88M.
- 2014-03-31: Cash $3.70M.
- 2013-12-31: Cash $6.00M.
| Period end | Cash |
|---|---|
| 2014-12-31 | $18.20M 10-K · filed 2015-03-11 |
| 2014-06-30 | $39.88M 10-Q · filed 2014-08-14 |
| 2014-03-31 | $3.70M 10-Q · filed 2014-05-15 |
| 2013-12-31 | $6.00M 10-K/A · filed 2015-07-09 |
| 2013-09-30 | $13.41M 10-Q/A · filed 2015-07-09 |
| 2013-06-30 | $286.51K 10-Q · filed 2013-09-16 |
| 2013-03-31 | $2.50M 10-Q/A · filed 2013-09-16 |
| 2012-12-31 | $11.39K 10-Q/A · filed 2015-07-09 |
| 2012-11-30 | $3.90K 10-Q · filed 2013-03-06 |
| 2012-08-31 | $3.90K 10-Q · filed 2012-10-10 |
| 2012-05-31 | $3.90K 10-Q · filed 2012-08-08 |
| 2012-02-29 | $3.91K 10-Q · filed 2013-03-06 |
| 2012-02-28 | $3.91K 10-Q · filed 2012-10-10 |
| 2011-12-31 | $10.05K 10-K/A · filed 2013-09-16 |
| 2011-11-30 | $3.89K 10-Q · filed 2013-03-06 |
| 2011-08-31 | $3.91K 10-Q · filed 2012-10-10 |
| 2011-05-31 | $3.93K 10-Q · filed 2012-08-08 |
| 2011-03-01 | $3.96K 10-K · filed 2012-05-24 |
| 2011-02-28 | $3.96K 10-Q · filed 2013-03-06 |
| 2010-11-30 | $4.54K 10-Q · filed 2012-01-11 |
| 2010-08-31 | $4.63K 10-Q/A · filed 2012-06-06 |
| 2010-02-28 | $4.65K 10-Q/A · filed 2012-06-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |